These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10636381)

  • 1. Septic shock: finding the way through the maze.
    Rowe PM
    Lancet; 1999 Dec; 354(9195):2058. PubMed ID: 10636381
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Preface.
    Ronco C
    Blood Purif; 2014; 37 Suppl 1():1. PubMed ID: 24457486
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacterial DNA causes septic shock.
    Sparwasser T; Miethke T; Lipford G; Borschert K; Häcker H; Heeg K; Wagner H
    Nature; 1997 Mar; 386(6623):336-7. PubMed ID: 9121548
    [No Abstract]   [Full Text] [Related]  

  • 5. T cell mediated lethal shock induced by bacterial superantigens.
    Wagner H; Heeg K; Miethke T
    Behring Inst Mitt; 1992 Apr; (91):46-53. PubMed ID: 1524570
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endotoxin in the clinic and in experiments].
    Rumiantsev AG; Kasatkin VN; Kanaeva ES
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):110-4. PubMed ID: 7941855
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies and the treatment of gram-negative bacteremia and shock.
    Wolff SM
    N Engl J Med; 1991 Feb; 324(7):486-8. PubMed ID: 1988835
    [No Abstract]   [Full Text] [Related]  

  • 8. TREM-1 amplifies inflammation and is a crucial mediator of septic shock.
    Bouchon A; Facchetti F; Weigand MA; Colonna M
    Nature; 2001 Apr; 410(6832):1103-7. PubMed ID: 11323674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of bacterial infections: some determinants of virulence in Gram negative bacteria.
    Woolcock JB
    Aust Vet J; 1985 Jun; 62(6):177-81. PubMed ID: 3904701
    [No Abstract]   [Full Text] [Related]  

  • 10. New insights into the pathogenesis and therapy of sepsis and septic shock.
    Llewelyn M; Cohen J
    Curr Clin Top Infect Dis; 2001; 21():148-71. PubMed ID: 11572150
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant soluble CD14 inhibits LPS-induced mortality in a murine model.
    Goyert SM; Haziot A
    Prog Clin Biol Res; 1995; 392():479-83. PubMed ID: 8524955
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
    Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
    Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endotoxins of gram-negative bacteria, cytokines and the concept of septic shock: present state of the problem].
    Beloborodov VB; Dzheksenbaev OSh
    Anesteziol Reanimatol; 1991; (4):41-3. PubMed ID: 1952239
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of endotoxin shock and endotoxin hypersensitivity.
    Galanos C; Freudenberg MA
    Immunobiology; 1993 Apr; 187(3-5):346-56. PubMed ID: 8330903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding of the pathogenesis of gram-negative shock.
    Waage A; Brandtzaeg P; Espevik T; Halstensen A
    Infect Dis Clin North Am; 1991 Dec; 5(4):781-91. PubMed ID: 1783767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms involved in the pathogenesis of septic shock.
    López-Bojórquez LN; Dehesa AZ; Reyes-Terán G
    Arch Med Res; 2004; 35(6):465-79. PubMed ID: 15631870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1 inhibitor suppresses the endotoxic activity of a wide range of lipopolysaccharides and interacts with live gram-negative bacteria.
    Mejia P; Davis AE
    Shock; 2012 Aug; 38(2):220-5. PubMed ID: 22576004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial endotoxins and their effects].
    Bertók L
    Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation in septic shock due to gram-negative and gram-positive bacteria.
    León C; Rodrigo MJ; Tomasa A; Gallart MT; Latorre FJ; Rius J; Brugués J
    Crit Care Med; 1982 May; 10(5):308-10. PubMed ID: 6918253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.